ZELLUNA ASA (ZLNA.OL) Fundamental Analysis & Valuation

OSL:ZLNA • NO0013524942

Current stock price

19.643 NOK
+0.24 (+1.24%)
Last:

This ZLNA.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ZLNA.OL Profitability Analysis

1.1 Basic Checks

  • In the past year ZLNA has reported negative net income.
  • In the past year ZLNA has reported a negative cash flow from operations.
  • In the past 5 years ZLNA always reported negative net income.
  • In the past 5 years ZLNA always reported negative operating cash flow.
ZLNA.OL Yearly Net Income VS EBIT VS OCF VS FCFZLNA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

  • With a Return On Assets value of -269.09%, ZLNA is not doing good in the industry: 92.41% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -337.63%, ZLNA is doing worse than 62.03% of the companies in the same industry.
Industry RankSector Rank
ROA -269.09%
ROE -337.63%
ROIC N/A
ROA(3y)-86.89%
ROA(5y)-61.71%
ROE(3y)-116.09%
ROE(5y)-80.15%
ROIC(3y)N/A
ROIC(5y)N/A
ZLNA.OL Yearly ROA, ROE, ROICZLNA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ZLNA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZLNA.OL Yearly Profit, Operating, Gross MarginsZLNA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

8

2. ZLNA.OL Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ZLNA remains at a similar level compared to 1 year ago.
  • ZLNA has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ZLNA has a worse debt to assets ratio.
ZLNA.OL Yearly Shares OutstandingZLNA.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ZLNA.OL Yearly Total Debt VS Total AssetsZLNA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • ZLNA has an Altman-Z score of 11.91. This indicates that ZLNA is financially healthy and has little risk of bankruptcy at the moment.
  • ZLNA has a better Altman-Z score (11.91) than 89.87% of its industry peers.
  • There is no outstanding debt for ZLNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.91
ROIC/WACCN/A
WACCN/A
ZLNA.OL Yearly LT Debt VS Equity VS FCFZLNA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • ZLNA has a Current Ratio of 3.56. This indicates that ZLNA is financially healthy and has no problem in meeting its short term obligations.
  • ZLNA has a better Current ratio (3.56) than 72.15% of its industry peers.
  • A Quick Ratio of 3.56 indicates that ZLNA has no problem at all paying its short term obligations.
  • ZLNA has a better Quick ratio (3.56) than 77.22% of its industry peers.
Industry RankSector Rank
Current Ratio 3.56
Quick Ratio 3.56
ZLNA.OL Yearly Current Assets VS Current LiabilitesZLNA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1

3. ZLNA.OL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.78% over the past year.
EPS 1Y (TTM)10.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, ZLNA will show a very strong growth in Earnings Per Share. The EPS will grow by 34.81% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y89.02%
EPS Next 2Y34.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZLNA.OL Yearly Revenue VS EstimatesZLNA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2M 4M 6M 8M
ZLNA.OL Yearly EPS VS EstimatesZLNA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 -20 -40 -60

1

4. ZLNA.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ZLNA. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZLNA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZLNA.OL Price Earnings VS Forward Price EarningsZLNA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZLNA.OL Per share dataZLNA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ZLNA's earnings are expected to grow with 34.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.81%
EPS Next 3YN/A

0

5. ZLNA.OL Dividend Analysis

5.1 Amount

  • No dividends for ZLNA!.
Industry RankSector Rank
Dividend Yield 0%

ZLNA.OL Fundamentals: All Metrics, Ratios and Statistics

ZELLUNA ASA

OSL:ZLNA (3/24/2026, 3:40:25 PM)

19.643

+0.24 (+1.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners14.77%
Inst Owner ChangeN/A
Ins Owners0.72%
Ins Owner ChangeN/A
Market Cap516.02M
Revenue(TTM)5.00K
Net Income(TTM)-212.87M
Analysts42.22
Price Target25.5 (29.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 103204.32
P/FCF N/A
P/OCF N/A
P/B 8.18
P/tB 11.17
EV/EBITDA N/A
EPS(TTM)-38.7
EYN/A
EPS(NY)-7.96
Fwd EYN/A
FCF(TTM)-5.97
FCFYN/A
OCF(TTM)-5.73
OCFYN/A
SpS0
BVpS2.4
TBVpS1.76
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -269.09%
ROE -337.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-86.89%
ROA(5y)-61.71%
ROE(3y)-116.09%
ROE(5y)-80.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 150.92%
Cap/Sales 125260%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.56
Quick Ratio 3.56
Altman-Z 11.91
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2.96%
Cap/Depr(5y)41.24%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.69%
EPS Next Y89.02%
EPS Next 2Y34.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.76%
OCF growth 3YN/A
OCF growth 5YN/A

ZELLUNA ASA / ZLNA.OL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ZELLUNA ASA (ZLNA.OL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ZLNA.OL.


Can you provide the valuation status for ZELLUNA ASA?

ChartMill assigns a valuation rating of 1 / 10 to ZELLUNA ASA (ZLNA.OL). This can be considered as Overvalued.


What is the profitability of ZLNA stock?

ZELLUNA ASA (ZLNA.OL) has a profitability rating of 0 / 10.


How financially healthy is ZELLUNA ASA?

The financial health rating of ZELLUNA ASA (ZLNA.OL) is 8 / 10.


What is the expected EPS growth for ZELLUNA ASA (ZLNA.OL) stock?

The Earnings per Share (EPS) of ZELLUNA ASA (ZLNA.OL) is expected to grow by 89.02% in the next year.